| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4025916 | Ophthalmology | 2014 | 9 Pages |
Abstract
Bromfenac ophthalmic solution 0.07% dosed once daily was clinically safe and effective compared with placebo for the treatment of ocular inflammation and pain in subjects who had undergone cataract surgery and may be a beneficial addition to the current standard of care, which commonly includes ophthalmic antibiotics and corticosteroids.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Thomas R. MD, Damien F. MD, James H. MD, James A. BSc(Med), MD, Bromfenac Ophthalmic Solution 0.07% Once Daily Study Group Bromfenac Ophthalmic Solution 0.07% Once Daily Study Group,